First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula
- PMID: 1491608
- DOI: 10.1007/BF02535870
First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula
Abstract
Very low birth weight (VLBW) infants (748-1390 g, n = 65) were randomly assigned to receive control or marine oil-supplemented formula when they achieved intakes > 454 kJ (110 kcal)/kg/d of a formula designed for VLBW infants. Study formulas with or without marine oil were provided until 79 wk of postconceptional age (PCA), first in a formula designed for preterm infants followed by a formula designed for term infants. Infants were studied at regular intervals through 92 wk PCA. Weight, length, and head circumference were determined by standardized procedures and normalized to the National Center for Health Statistics figures for growth of infants born at term of the same age and gender. Mean normalized weight, weight-to-length, and head circumference were greatest at 48 wk and decreased thereafter. The decline in normalized weight was greater in infants fed the marine oil-supplemented formula. Beginning at 40 wk, marine oil-supplemented infants compared to controls had significantly poorer Z-scores for weight, length and head circumference. In addition, birth order (negatively) and maternal height (positively) influenced weight and length achievement in infancy as shown previously in infants born at term.
Similar articles
-
Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: soy oil and marine oil supplementation of formula.J Pediatr. 1994 Apr;124(4):612-20. doi: 10.1016/s0022-3476(05)83144-0. J Pediatr. 1994. PMID: 7908693 Clinical Trial.
-
Essentiality of dietary omega 3 fatty acids for premature infants: plasma and red blood cell fatty acid composition.Lipids. 1992 Nov;27(11):886-95. doi: 10.1007/BF02535868. Lipids. 1992. PMID: 1362792
-
Dietary essential fatty acid supply and visual acuity development.Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3242-53. Invest Ophthalmol Vis Sci. 1992. PMID: 1399429 Clinical Trial.
-
Lessons learned from randomizing infants to marine oil-supplemented formulas in nutrition trials.J Pediatr. 1994 Nov;125(5 Pt 2):S33-8. doi: 10.1016/s0022-3476(06)80734-1. J Pediatr. 1994. PMID: 7965451 Review.
-
Polyunsaturated fatty acids and infant growth.Lipids. 2001 Sep;36(9):901-11. doi: 10.1007/s11745-001-0800-y. Lipids. 2001. PMID: 11724462 Review.
Cited by
-
Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients.J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):212-8. doi: 10.1097/MPG.0b013e3181bbf51e. J Pediatr Gastroenterol Nutr. 2010. PMID: 20038849 Free PMC article.
-
Use of Fish Oil-Based Lipid Emulsions in Infants With Intestinal Failure-Associated Liver Disease: A Case Series.Infant Child Adolesc Nutr. 2014 Feb;6(1):6-13. doi: 10.1177/1941406413513461. Infant Child Adolesc Nutr. 2014. PMID: 24527173 Free PMC article.
-
Dietary n-3 and n-6 PUFA enhance DHA incorporation in retinal phospholipids without affecting PGE(1) and PGE (2) levels.Lipids. 2009 May;44(5):465-70. doi: 10.1007/s11745-009-3289-3. Epub 2009 Feb 26. Lipids. 2009. PMID: 19242743
-
Lymphatic fatty acids from rats fed human milk and formula supplemented with fish oil.Lipids. 1995 Jul;30(7):673-6. doi: 10.1007/BF02537005. Lipids. 1995. PMID: 7564923
-
Erythrocyte fatty acids of term infants fed either breast milk, standard formula, or formula supplemented with long-chain polyunsaturates.Lipids. 1995 Oct;30(10):941-8. doi: 10.1007/BF02537486. Lipids. 1995. PMID: 8538382 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical